Here are what the editors at HealthDay consider to be the most important developments in Otolaryngology for October 2018. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice.
AMA Announces Initiative to Reinvent Physician Training
TUESDAY, Oct. 30, 2018 (HealthDay News) — The American Medical Association (AMA) today announced a new $15 million competitive grant initiative, the “Reimagining Residency” initiative, aimed at improving residency training.
Many Hospitals Noncompliant With Record Request Regulations
MONDAY, Oct. 29, 2018 (HealthDay News) — Among top-ranked U.S. hospitals, data reveal discrepancies in information provided to patients regarding medical records release processes as well as noncompliance with state and federal regulations, according to a study published online Oct. 5 in JAMA Network Open.
Smoking Associated With Head, Neck Surgery Complications
MONDAY, Oct. 29, 2018 (HealthDay News) — Smoking is associated with increased rates of postoperative wound disruption and subsequent reoperation among patients undergoing free flap reconstruction of the head and neck, according to a study published online Oct. 18 in JAMA Facial Plastic Surgery.
Abstract/Full Text (subscription or payment may be required)
Trump Administration Announces Plan to Cut Drug Prices
FRIDAY, Oct. 26, 2018 (HealthDay News) — In an effort to cut high drug costs, the prices paid by Medicare for certain prescription drugs would be based on those in other advanced industrial nations, according to a proposal announced Oct. 25 by the Trump administration.
HHS Study
New York Times Article
Pace of Change Has Accelerated in Alternative Payment Models
THURSDAY, Oct. 25, 2018 (HealthDay News) — The impact of alternative payment models (APMs) on physician practices has been described in a study published by the RAND Corp. and the American Medical Association.
Most Supplements Contain Prohibited Stimulants
WEDNESDAY, Oct. 24, 2018 (HealthDay News) — Many supplements contain one or more stimulants that have been the subject of U.S. Food and Drug Administration-issued public notices, according to a research letter published online Oct. 22 in JAMA Internal Medicine.
Abstract/Full Text (subscription or payment may be required)
Editor’s Note (subscription or payment may be required)
White House Unveils New Insurance Option for Small Firms
TUESDAY, Oct. 23, 2018 (HealthDay News) — A plan to allow small businesses to use tax-free accounts to provide health coverage for employees was announced today by the Trump administration.
AP News Article
More Information
Light Use of Topical Skin Tx Before Radiotherapy Seems Safe
Decision Guide Helps ID Referral for Swallowing Assessment 
Review: Results of Endolymphatic Sac Surgery Mixed in Meniere Disease 
Middle Ear Effusion Up for Children With Tracheostomy on Ventilator 
Psychoneurological Distress Up With Nasal Septum Deviation 
150+ Minutes of Social Media Daily Tied to Depression in Adults 
Therapist-Led Online Cognitive Behavioral Therapy Aids Depression 
Internet-Based Cognitive-Behavioral Therapy Aids Children"s Anxiety Symptoms 
Couples" Coping Skills Help Reduce Depression in GI Cancer Survivors 
